Overview
Denali Health is an integrated research organization that partners with pharmaceutical companies to run clinical trials, focusing on solving patient recruitment bottlenecks. It uses a network of clinical research sites to identify, enroll, and manage trial participants, aiming to speed up study start-up and overall timelines. The company distinguishes itself by targeting studies it can reliably deliver on and aiming to be among the top three global enrollers for every trial, providing sponsors a more dependable alternative to traditional site networks. Its work spans multiple therapeutic areas, including CNS disorders, cardiometabolic diseases, wound care, and vaccine research, with a goal of accelerating drug development by improving patient recruitment and trial execution.
Work here?Claim your company
Simplify's take
What believers are saying
- Denali Health’s August 2026 hiring shows active expansion across research and nursing roles.
- The company markets 40% faster enrollment and 5x faster study start-up on its site.
- Pediatric-focused recruitment capabilities fit chronic recruitment bottlenecks pharma sponsors still pay premiums to solve.
What critics are saying
- No public funding, revenue, or sponsor roster signals fragile commercial traction in 2026.
- Open jobs in August 2026 suggest staffing strain across Florida and Georgia sites.
- If recruitment misses targets, pharma sponsors can switch to larger networks like ICON or IQVIA.
What makes Denali Health unique
- Denali Health’s 2026 website centers on patient recruitment, not generic site staffing.
- Its 7-day call center and proprietary recruitment engine target hard-to-enroll pediatric studies.
- Plant City, Atlanta, and Stone Mountain sites give Denali Health local execution breadth.
Help us improve and share your feedback! Did you find this helpful?